StonvexLoading…
StonvexStonvexStonvexCore line items from AIZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.81B | $11.88B | $11.13B | $10.19B |
Operating Income | $1.09B | $927.30M | $806.80M | $349.90M |
Net Income | $872.70M | $760.20M | $642.50M | $276.60M |
EPS (Diluted) | $16.93 | $14.46 | $11.95 | $5.05 |
Total Assets | $36.29B | $35.02B | $33.64B | $33.12B |
Total Liabilities | $30.42B | $29.91B | $28.83B | $28.89B |
Cash & Equivalents | $1.83B | $1.81B | $1.63B | $1.54B |
Free Cash Flow OCF − CapEx | $1.60B | $1.11B | $935.60M | $410.60M |
Shares Outstanding | 49.79M | 50.83M | 51.96M | 52.83M |